Cydar

Cydar

Cardiology & Cardiovascular Health

About Cydar

Cydar Medical is a medical technology company founded in 2014 that specializes in transforming minimally invasive image-guided surgery through artificial intelligence and advanced imaging solutions. The company's flagship product, Cydar Maps, is a comprehensive Software-as-a-Medical Device (SaMD) platform that supports the entire surgical workflow—from pre-operative planning to intraoperative guidance and post-operative analysis. The Cydar Image Guided Surgery Platform (CIGSP) leverages cloud-based AI technology and data fusion to empower clinical teams with actionable insights for faster, easier, and more informed surgical decisions. The platform creates 3D surgical plans using AI-enhanced vessel measurements, provides real-time intraoperative guidance with surgical precision, and enables automatic volume assessment for monitoring patient outcomes. Clinical evidence demonstrates significant improvements including reductions in radiation exposure, procedure times, and contrast agent use. Cydar Medical serves healthcare providers including hospitals, health systems, and vascular surgery departments primarily in the United States, United Kingdom, and European Union. The platform is designed for complex endovascular aortic procedures and other image-guided minimally invasive surgeries. The company's technology integrates seamlessly with existing hospital systems including PACS and operating room displays, while maintaining GDPR and HIPAA compliance. Cydar also partners with innovative software companies to accelerate the deployment of AI applications in surgical settings, providing a centralized framework that simplifies procurement, implementation, and ongoing support for healthcare institutions.

Mission & Story

Mission

Cydar's mission is to advance the quality of care for patients globally by using artificial intelligence (AI) to improve image-guided, minimally invasive surgical procedures.

Founding Story

Cydar Medical was founded in 2014 with the goal to improve patient outcomes and help shape the future of surgery with technology that delivers real, measurable impact. Co-founder Graeme Penney serves as Chief Scientific Officer.

Clinical Focus

Medical conditions and clinical areas addressed by Cydar.

Endovascular aortic proceduresComplex EVAR (Endovascular Aneurysm Repair)Vascular surgeryImage-guided minimally invasive surgical procedures

Who It Serves

Health SystemsHospitalsVascular Surgery DepartmentsAcademic Medical Centers

Milestones & Awards

Recent Milestones

Expansion of Cydar Maps solution for greater efficiency (2025), ongoing deployment across major healthcare systems

Key Partnerships

Software companies deploying AI applications via CIGSP platformHealthcare providers across US, EU, and UK

Social & Media

Follow on

Company Details

Founded
2014
Headquarters
Wilmington, Delaware, USA

Work here?

Claim this listing to update company information and connect with our audience.

Claim This Listing

Security & Compliance

GDPRHIPAAISMS certified
Last updated Jun 28, 2026

Similar Companies in this Market

View all 64
AccurKardia

AccurKardia

AI-powered platform for cardiovascular disease detection and cardiac risk assessment.

Acorai

Acorai

AI platform for cardiovascular disease detection and cardiac risk assessment.

Aisap

Aisap

11-50 employees

AISAP provides FDA-cleared AI-powered diagnostic algorithms embedded in an operating system for point-of-care ultrasound (POCUS) devices. The platform enables rapid, expert-level cardiac imaging interpretation at the bedside, helping physicians detect structural heart disease early and make faster clinical decisions across hospitals, clinics, and screening programs.

AliveCor

AliveCor

AliveCor develops FDA-cleared, AI-powered ECG devices and software platforms for cardiac monitoring. The company offers portable ECG solutions ranging from consumer personal devices to clinical-grade 12-lead systems, serving patients, healthcare providers, biopharma companies, and health systems with remote and connected cardiac care.

Anumana AI

Anumana AI

series c · 175 employees

Anumana AI develops and delivers AI-driven ECG algorithms to enable early diagnosis and intervention for cardiovascular conditions.

Artrya

Artrya

11-50 employees

Artrya develops AI-powered solutions for rapid assessment of chest pain patients in emergency and primary care settings. The company's technology analyzes coronary computed tomography angiography (CCTA) to detect arterial plaque and stratify patient risk within minutes.

Bay Labs

Bay Labs

Bay Labs is a health AI company focused on cardiology and cardiovascular health. The company's website is currently under construction with limited public information available.

BunkerHill Health

BunkerHill Health

Bunkerhill Health provides Carebricks, an AI-powered platform that enables health systems to design, deploy, and operationalize AI agents across clinical and operational workflows. The platform reasons across patient data and automates actions within existing EHR systems.

Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.